212 related articles for article (PubMed ID: 30627824)
21. Anti-cancer mechanism and possibility of nano-suspension formulations for a marine algae product fucoxanthin.
Muthuirulappan S; Francis SP
Asian Pac J Cancer Prev; 2013; 14(4):2213-6. PubMed ID: 23725114
[TBL] [Abstract][Full Text] [Related]
22. Advances in Fucoxanthin Research for the Prevention and Treatment of Inflammation-Related Diseases.
Guan B; Chen K; Tong Z; Chen L; Chen Q; Su J
Nutrients; 2022 Nov; 14(22):. PubMed ID: 36432455
[TBL] [Abstract][Full Text] [Related]
23. Health benefits of fucoxanthin in the prevention of chronic diseases.
Bae M; Kim MB; Park YK; Lee JY
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Nov; 1865(11):158618. PubMed ID: 31931174
[TBL] [Abstract][Full Text] [Related]
24. Fucoxanthin: a marine carotenoid exerting anti-cancer effects by affecting multiple mechanisms.
Kumar SR; Hosokawa M; Miyashita K
Mar Drugs; 2013 Dec; 11(12):5130-47. PubMed ID: 24351910
[TBL] [Abstract][Full Text] [Related]
25. Fucoxanthin@Polyvinylpyrrolidone Nanoparticles Promoted Oxidative Stress-Induced Cell Death in Caco-2 Human Colon Cancer Cells.
Sui Y; Gu Y; Lu Y; Yu C; Zheng J; Qi H
Mar Drugs; 2021 Feb; 19(2):. PubMed ID: 33562511
[TBL] [Abstract][Full Text] [Related]
26. Cancer preventive efficacy of marine carotenoid fucoxanthin: cell cycle arrest and apoptosis.
Rengarajan T; Rajendran P; Nandakumar N; Balasubramanian MP; Nishigaki I
Nutrients; 2013 Dec; 5(12):4978-89. PubMed ID: 24322524
[TBL] [Abstract][Full Text] [Related]
27. Effects of Low-Molecular-Weight Fucoidan and High Stability Fucoxanthin on Glucose Homeostasis, Lipid Metabolism, and Liver Function in a Mouse Model of Type II Diabetes.
Lin HV; Tsou YC; Chen YT; Lu WJ; Hwang PA
Mar Drugs; 2017 Apr; 15(4):. PubMed ID: 28387741
[TBL] [Abstract][Full Text] [Related]
28. Fucoxanthin and Colorectal Cancer Prevention.
Terasaki M; Kubota A; Kojima H; Maeda H; Miyashita K; Kawagoe C; Mutoh M; Tanaka T
Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34069132
[TBL] [Abstract][Full Text] [Related]
29. Fucoxanthin Elicits Epigenetic Modifications, Nrf2 Activation and Blocking Transformation in Mouse Skin JB6 P+ Cells.
Yang Y; Yang I; Cao M; Su ZY; Wu R; Guo Y; Fang M; Kong AN
AAPS J; 2018 Feb; 20(2):32. PubMed ID: 29603113
[TBL] [Abstract][Full Text] [Related]
30. Astaxanthin anticancer effects are mediated through multiple molecular mechanisms: A systematic review.
Faraone I; Sinisgalli C; Ostuni A; Armentano MF; Carmosino M; Milella L; Russo D; Labanca F; Khan H
Pharmacol Res; 2020 May; 155():104689. PubMed ID: 32057895
[TBL] [Abstract][Full Text] [Related]
31. Fucoxanthin and its deacetylated product, fucoxanthinol, induce apoptosis of primary effusion lymphomas.
Yamamoto K; Ishikawa C; Katano H; Yasumoto T; Mori N
Cancer Lett; 2011 Jan; 300(2):225-34. PubMed ID: 21078541
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of tumor growth in vitro and in vivo by fucoxanthin against melanoma B16F10 cells.
Kim KN; Ahn G; Heo SJ; Kang SM; Kang MC; Yang HM; Kim D; Roh SW; Kim SK; Jeon BT; Park PJ; Jung WK; Jeon YJ
Environ Toxicol Pharmacol; 2013 Jan; 35(1):39-46. PubMed ID: 23228706
[TBL] [Abstract][Full Text] [Related]
33. Fucoxanthin bioavailability from fucoxanthin-fortified milk: In vivo and in vitro study.
Mok IK; Lee JK; Kim JH; Pan CH; Kim SM
Food Chem; 2018 Aug; 258():79-86. PubMed ID: 29655757
[TBL] [Abstract][Full Text] [Related]
34. Preparation of Fucoxanthin-Loaded Nanoparticles Composed of Casein and Chitosan with Improved Fucoxanthin Bioavailability.
Koo SY; Mok IK; Pan CH; Kim SM
J Agric Food Chem; 2016 Dec; 64(49):9428-9435. PubMed ID: 27960297
[TBL] [Abstract][Full Text] [Related]
35. Single and repeated oral dose toxicity study of fucoxanthin (FX), a marine carotenoid, in mice.
Beppu F; Niwano Y; Tsukui T; Hosokawa M; Miyashita K
J Toxicol Sci; 2009 Oct; 34(5):501-10. PubMed ID: 19797858
[TBL] [Abstract][Full Text] [Related]
36. Sensitization of gastric cancer cells to alkylating agents by glaucocalyxin B via cell cycle arrest and enhanced cell death.
Ur Rahman MS; Zhang L; Wu L; Xie Y; Li C; Cao J
Drug Des Devel Ther; 2017; 11():2431-2441. PubMed ID: 28860714
[TBL] [Abstract][Full Text] [Related]
37. Fucoxanthin Inhibits Myofibroblast Differentiation and Extracellular Matrix Production in Nasal Polyp-Derived Fibroblasts via Modulation of Smad-Dependent and Smad-Independent Signaling Pathways.
Jung H; Lee DS; Park SK; Choi JS; Jung WK; Park WS; Choi IW
Mar Drugs; 2018 Sep; 16(9):. PubMed ID: 30201895
[TBL] [Abstract][Full Text] [Related]
38. Fucoxanthin Activates Apoptosis via Inhibition of PI3K/Akt/mTOR Pathway and Suppresses Invasion and Migration by Restriction of p38-MMP-2/9 Pathway in Human Glioblastoma Cells.
Liu Y; Zheng J; Zhang Y; Wang Z; Yang Y; Bai M; Dai Y
Neurochem Res; 2016 Oct; 41(10):2728-2751. PubMed ID: 27394418
[TBL] [Abstract][Full Text] [Related]
39. Protective Effects of Fucoxanthin on High Glucose- and 4-Hydroxynonenal (4-HNE)-Induced Injury in Human Retinal Pigment Epithelial Cells.
Chiang YF; Chen HY; Chang YJ; Shih YH; Shieh TM; Wang KL; Hsia SM
Antioxidants (Basel); 2020 Nov; 9(12):. PubMed ID: 33255669
[TBL] [Abstract][Full Text] [Related]
40. Salivary Glycine Is a Significant Predictor for the Attenuation of Polyp and Tumor Microenvironment Formation by Fucoxanthin in AOM/DSS Mice.
Terasaki M; Masaka S; Fukada C; Houzaki M; Endo T; Tanaka T; Maeda H; Miyashita K; Mutoh M
In Vivo; 2019; 33(2):365-374. PubMed ID: 30804114
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
